-transparent.png){kind=logo}
Prognostic parameters of patients with stomach and colorectal cancer, which could be established within a few days during hospitalization of patients for primary treatment, were characterized and compared in a clinical investigation with observed postoperative survival. Statistical analysis was based on data from a long-term follow-up study of 563 colorectal and 390 stomach cancer patients registered since 1974. The potential prognostic parameters included resectability, tumor extension, and preoperative serum CEA levels. Statistical examination revealed that each of the parameters was associated with highly significant differences in survival of the patients. Combinations of clinical parameters with distinct ranges of preoperative serum CEA levels gave additional valuable prognostic information, thus facilitating the management of patients for adjuvant postoperative treatment.
H J Staab, and
F A Anderer, and
T Brummendorf, and
R Fischer
January 2021,
Journal of oncology,
H J Staab, and
F A Anderer, and
T Brummendorf, and
R Fischer
August 1978,
The New England journal of medicine,
H J Staab, and
F A Anderer, and
T Brummendorf, and
R Fischer
January 2012,
La Tunisie medicale,
H J Staab, and
F A Anderer, and
T Brummendorf, and
R Fischer
July 1986,
Indian journal of pathology & microbiology,
H J Staab, and
F A Anderer, and
T Brummendorf, and
R Fischer
January 2011,
Hepato-gastroenterology,
H J Staab, and
F A Anderer, and
T Brummendorf, and
R Fischer
January 2017,
Cancer biomarkers : section A of Disease markers,
H J Staab, and
F A Anderer, and
T Brummendorf, and
R Fischer
April 2015,
International surgery,
H J Staab, and
F A Anderer, and
T Brummendorf, and
R Fischer
January 2022,
Technology in cancer research & treatment,
H J Staab, and
F A Anderer, and
T Brummendorf, and
R Fischer
June 1994,
Fukushima journal of medical science,
H J Staab, and
F A Anderer, and
T Brummendorf, and
R Fischer
January 2000,
Japanese journal of clinical oncology,
